PTK2 and neoplasm: However, in breast carcinoma cells, FAK signaling also enhances matrix metalloproteinase (Hsia et al., 2003; Wu et al., 2005) and urokinase plasminogen activator expression (Mitra et al., 2006a), which both act in the tumor microenvironment to facilitate matrix degradation and cell invasion.